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ABSTRACT 
 
The world cannot live without blood donors, since their donations are an essential and 
irreplaceable act to save patient lives. Attending that the population ageing evolution 
leads to a demographic change, we must be concerned whether the demand of Red Cell 
Concentrates will overcome the existing donations in the future. This is an applied study 
to the region of Algarve. In particular, it is based on the reality of the Algarve Hospital 
Centre, whose number of donors, donations, patients and transfused Red Cell 
Concentrates are evaluated over a five-year period, from 2010 to 2014. A forecast for Red 
Cell Concentrates demand for 2060 was obtained in four different scenarios. According 
to the results, by 2060 the population of Algarve will decrease 9.0%, blood donors and 
blood donations will decrease 24.0% and Red Cell Concentrates demand will increase 
35.0%. Through a linear regression, 2046 was established as the year in which the number 
of blood donors/donations will equalize the demand of Red Cell Concentrates. In actual 
conditions, the forecast for 2060 reveals that, on average, the demand of Red Cell 
Concentrates will exceed donor/donations. The Algarve Hospital Centre would then focus 
its efforts on blood donation promotion among younger age groups (18 and older), as well 
as in the increase of donation frequency. Another important issue is the investment in the 
improvement of good transfusion practices, the optimization of patient and blood 
transfusion management in order to make possible the satisfaction of Red Cell 
Concentrates needs in the future. 
Keywords: Demographic Changes; Red Cell Concentrates Supply; Red Cell Concentrates 
Demand; Forecast; Population from Algarve. 
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RESUMO 
 
O mundo não pode viver sem dadores de sangue, uma vez que as suas dádivas são um ato 
essencial e insubstituível para salvar a vida de doentes. Apesar dos avanços da ciência e 
das várias descobertas, ainda não foi encontrado um substituto eficaz para o sangue 
humano. A disponibilidade de sangue e dos componentes sanguíneos, utilizados para fins 
terapêuticos em contexto hospitalar, depende da dádiva voluntária dos cidadãos, sendo 
esta denominada por dádiva homóloga. Atendendo à evolução do envelhecimento da 
população e das consequentes alterações demográficas que daí advêm, devemo-nos 
preocupar com a possibilidade de, futuramente, as necessidades transfusionais 
hospitalares, relativamente ao número de Concentrados Eritrocitários, puderem 
ultrapassar o número das dádivas sanguíneas. O presente estudo foi realizado na região 
do Algarve, no Centro Hospitalar do Algarve, onde o número de dadores, dádivas, doentes 
transfundidos e Concentrados Eritrocitários administrados, foram avaliados durante um 
período de cinco anos, de 2010 até 2014. A criação da entidade e início da atividade do 
Centro Hospitalar do Algarve remonta a 1 julho de 2013, em conformidade com o 
Decreto-lei n.º 69/2013 de 17 de maio, que determinou a criação do Centro Hospitalar do 
Algarve, E.P.E por fusão e consequente extinção do Hospital de Faro E.P.E e do Centro 
Hospitalar do Barlavento Algarvio, E.P.E., sendo a única entidade hospitalar pública que 
assegura a prestação de cuidados de saúde a toda a população algarvia. Entre 2011 e 2013 
foram realizados diversos estudos e trabalhos levados a cabo pela Administração Central 
do Sistema de Saúde, I.P., Grupo Técnico para a Reforma Hospitalar, Entidade 
Reguladora da Saúde e Administrações Regionais de Saúde, com o intuito de classificar 
as instituições hospitalares e serviços do SNS resultando na Portaria n.º 82/2014 de 10 de 
abril cujo objetivo passa por estabelecer os critérios que permitem categorizar os serviços 
e estabelecimentos do Serviço Nacional de Saúde, de acordo com a natureza das suas 
responsabilidades e quadro de valências exercidas, e o seu posicionamento na rede 
hospitalar e proceder à sua classificação. Assim sendo, as instituições podem ser 
classificadas em quatro grupos: I, II, III e IV. O Centro Hospitalar do Algarve pertence 
ao Grupo II e apresenta as seguintes valências médicas e cirúrgicas: medicina interna, 
neurologia, pediatria médica, psiquiatria, cirurgia geral, ginecologia, ortopedia, 
anestesiologia, radiologia, patologia clínica, imunohemoterapia e medicina física e de 
reabilitação, oftalmologia, pneumologia, cardiologia, reumatologia, gastrenterologia, 
nefrologia, hematologia clínica, infeciologia, oncologia médica, neonatologia, imuno-
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alergologia, ginecologia/obstetrícia, dermato-venerologia, otorrinolaringologia, urologia, 
cirurgia vascular, neurocirurgia, anatomia patológica, medicina nuclear e 
neurorradiologia. Em Portugal, é o Instituto Português do Sangue e da Transplantação, I. 
P., que tem por missão garantir e regular, a nível nacional, a atividade da medicina 
transfusional e de transplantação e garantir a dádiva, colheita, análise, processamento, 
preservação, armazenamento e distribuição de sangue humano, de componentes 
sanguíneos, de órgãos, tecidos e células de origem humana. O Decreto-Lei nº 185/2015, 
de 2 de setembro que transpõe a Diretiva n.º 2014/110/UE da Comissão, de 17 de 
dezembro de 2014, alterando a Diretiva n.º 2004/33/CE da Comissão, de 22 de março, no 
que se refere aos critérios de suspensão temporária de dadores de sangue relativamente a 
dádivas homólogas, e procede à segunda alteração do Decreto-Lei n.º 267/2007, de 24 de 
julho, que estabelece o regime jurídico da qualidade e segurança do sangue e dos 
componentes sanguíneos, respetivas exigências técnicas, requisitos de rastreabilidade e 
notificação de reações e incidentes adversos graves e as normas e especificações relativas 
ao sistema de qualidade dos serviços de sangue, com vista a assegurar um elevado nível 
de proteção da saúde pública. Uma distribuição de componentes sanguíneos apropriada 
só é possível quando o número de dádivas homólogas e o número de transfusões de 
hemoderivados estão equilibradas. Dadores do sexo masculino podem doar sangue no 
máximo quatro vezes ao ano enquanto dadores do sexo feminino podem realizar no 
máximo 3 dádivas anuais. Relativamente ao Algarve, a esperança média de vida tem 
vindo a aumentar e a população de doentes transfundida é constituída maioritariamente 
por uma faixa etária mais elevada (65 anos e superior). Neste estudo, projetaram-se para 
o ano de 2060 as necessidades transfusionais de Concentrados Eritrocitários em quatro 
cenários diferentes: Cenário Baixo, Cenário Central, Cenário Alto e Cenário Sem 
Migrações. Estes cenários resultam da conjugação de diferentes hipóteses relativas à 
futura evolução de cada componente demográfica. O Cenário Baixo resulta da conjugação 
das hipóteses pessimista para a fecundidade, central para a mortalidade e pessimista para 
as migrações; o Cenário Central associa as hipóteses de evolução central para a 
fecundidade, assim como para a mortalidade e a hipótese otimista para as migrações; o 
Cenário Alto combina as hipóteses de evolução otimista quer para a fecundidade, como 
para mortalidade e para as migrações; o Cenário Sem Migrações corresponde a um 
cenário idêntico ao Cenário Central, no entanto contempla a possibilidade de não 
ocorrência de migrações. Segundo o Instituto Nacional de Estatística, para qualquer um 
dos cenários de projeção apresentados, a população residente em Portugal tenderá a 
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diminuir até 2060. No Cenário Central a população apresentará uma diminuição de 10,5 
milhões de pessoas em 2012 para 8,6 milhões de pessoas em 2060. Simultaneamente com 
um declínio populacional, são esperadas alterações da estrutura etária da população, 
assim como um continuado e forte envelhecimento demográfico. De acordo com os 
resultados obtidos, até 2060 a população algarvia diminuirá 9,0%, os dadores e as dádivas 
sanguíneas diminuirão 24,0% e as necessidades de Concentrados Eritrocitários 
aumentarão 35,0%. Mediante condições atuais, uma projeção para o ano de 2060 
demonstra-nos que, em média, as necessidades de Concentrados Eritrocitários serão 
superiores aos dadores/dádivas existentes. Estabeleceu-se, através da estimação de um 
modelo de regressão linear, que em 2046 o número de dadores/dádivas sanguíneas será 
equivalente ao número de Concentrados Eritrocitários transfundidos no Centro Hospitalar 
do Algarve. O Centro Hospitalar do Algarve deverá concentrar esforços na promoção da 
dádiva sanguínea junto das faixas etárias mais jovens (18 anos e superior), assim como 
aumentar a frequência da dádiva. Outro aspeto a considerar será o investimento na 
melhoria das boas práticas transfusionais e na otimização da gestão do paciente e do 
sangue transfundido, de modo a, futuramente, se conseguir dar resposta às necessidades 
transfusionais de Concentrados Eritrocitários. 
 
Palavras-chave: Alterações Demográficas; Consumo Concentrados Eritrocitários; 
Necessidade Concentrados Eritrocitários; Projeção; População do Algarve. 
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Chapter 1. INTRODUCTION 
Until now, human blood cannot be produced or replaced artificially and for that 
reason homologous blood donations1 are extremely important. One of the most vital 
objectives for blood banks is to assure that blood supply is enough for the population 
needs (Páez, Esita, Newbold, Heddle and Blake, 2013). 
The world population reached 7.3 billion as of mid-2015 and in the last twelve 
years the world has added approximately one billion people. Looking at the global 
population, 60.0% lives in Asia (4.4 billion), 16.0% in Africa (1.2 billion), 10.0% in 
Europe (738 million), 9.0% in Latin America and the Caribbean (634 million), and the 
remaining 5.0% in Northern America (358 million) and Oceania (39 million) (United 
Nations, 2015a). In the 21st century it can be observed that the global population ageing 
is increasing in almost every country, which leads to an increment in the demand of 
economic and social resources (United Nations, 2015b). 
The development of medicine and the improvement of health conditions have led 
to great achievements and enormous challenges in humankind (Ahmed, Chaudhry and 
Khan, 2015; Zhavoronkov and Litovchenko, 2013). In Western Europe, United States of 
America, Canada and New Zealand, the life expectancy increased 30 years in 20th century 
(Christensen, Doblhammer, Rau, and Vaupel, 2009). The European population structure 
is changing, originating modifications in younger and elder age groups (Borkent-Raven, 
Janssen and Van Der Poel, 2010; Greinacher, Fendrich, Brzenska, Kiefel and Hoffmann, 
2011; Greinacher, Fendrich and Hoffmann, 2010; Jökulsdóttir, 2013; Lattimore, 
Wickenden and Brailsford, 2015). The proportion of the elderly population over the total 
population was 15.0% in 1971, 20.0% in 2000 and is estimated to be 30.0% in 2050 
(Christensen et al., 2009; Mota-Pinto et al., 2011). 
In Portugal, the Portuguese Official Statistics Institute (INE) reported that through 
these last years the demographic ageing is a remaining trend (Table 1.1) as a natural result 
of decreasing birth rates, increase in life expectancy and, more recently, the emigraton 
flows as observed in Figure 1.1 (INE, 2015). 
 
                                                     
1 Homologous donation is a donation from a donor who gives blood to be processed at a blood establishment 
and later on transfused to unknown recipient.  
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Table 1.1 Ageing ratio (No.) by Gender; Annual - INE, Annual Estimates of the Resident Population 
Age Index2 / Residence 
Local Portugal / No. 
Reference period of data 
2014 2013 2012 2011 2010 
Gender 
Male 114,50 110,10 106,00 103,20 100,10 
Female 169,40 163,20 157,50 153,20 148,80 
Source: INE (2015) 
 
 As it can be observed in Table1.1 along the years the age group from 0 to 14 years 
has been decreasing in comparison with age group 65 and older. In the years 2010, 2011, 
2012, 2013 and 2014 this last age group exceeded in 48.9, 56.4%, 63.5%, 73.3% and 
83.9% respectively the first age group. We can take into account that, in the 65 and more 
years age group, female gender is expressing higher values, in other words, the female 
population at that ages is more prevalent in the population. 
 
Figure 1.1 Rates of effective, natural and migratory growth (%), Portugal and NUTS3 II, 2009-2014  
 
Source: INE (2015) 
 
                                                     
2 Age index is calculated as the number of persons 65 years old or over per hundred persons under age 15. 
3 The NUTS classification (Nomenclature of Territorial Units for Statistics) is a hierarchical system for 
dividing up the economic territory of the EU for the collection, development and harmonisation of European 
regional statistics, socio-economic analysis of the regions and framing of EU regional policies. In Portugal 
exists three NUTS: NUTS I (consists of three units, corresponding to the territory of the continent and each 
of the autonomous regions of the Azores and Madeira); NUTS II (consists of seven units, five of which on 
the continent and the territories of the Azores and Madeira); and NUTS III (consists of 25 units, of which 
23 are on the mainland and 2 corresponding to the Azores and Madeira). 
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 Figure 1.1 reveals that the effective growth of the population is decreasing since 
2009 until 2014, where only 2009 presents a positive percentage value, meaning that the 
size of the population at the end of each year is smaller than the size of the population at 
the beginning of that same year, except for 2009 where the difference between the size of 
the population at the end and the beginning had a positive value. Natural growth rate 
decreased from 2009 to 2014, always with negative percentages, because the number of 
deaths exceeded the number of births. The migratory growth is calculated by the 
difference between immigration into and emigration from the area during the year and is 
negative when the number of emigrants exceeds the number of immigrants. There is a 
remarkable decreasing trend in migratory growth from 2009 until 2012, turning into 
negative rates around 2010. Although a slight recovery can be observed in 2013 and 2014, 
negative values are maintained.  
The indicator of life expectancy can be calculated at birth and/or at 65 years old. 
The life expectancy at birth summarizes the mortality risks at all ages of the population 
in a given time period, expressing the average number of years a person can expect to live 
along when exposed to mortality risks by age in that period (INE, 2014a). The life 
expectancy at 65 years old it is the average number of years that a person aged 65 can 
expect to live, if age-specific mortality rates at the time remain the same (INE, 2014a). 
The average life expectancy for the portuguese population at 65 years reached in 
2011-2013 18.97 years for both genders, being 17.07 years for men and 20.40 years for 
women. In this three years period, the Algarve region showed the highest values for life 
expectancy at age 65 for the total of the population (19.17 years) in which we have 17.31 
years for men and 20.75 years for women (INE, 2014a). 
The fact that we attend to a general ageing of the population, to which the Algarve 
population is no exception, had led us to investigate if the provision of health care will 
not be jeopardized in the future, becoming a matter of imperativeness concern. The life 
expectancy increase, the migration flows and economic capacity may lead to a change in 
the population of blood donors in the Algarve region. Additionally, it must be taken in 
consideration that the Portuguese law provides criteria regarding the age limits of donors 
and periodicity of donation. 
Blood bank services manage to get a balance between the availability of blood 
homologous donations and the demand of blood components for transfusion. The 
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population ageing and the average of Portuguese life expectancy along with the 
possibility of an increase of Red Cell Concentrates (RCC) requests, can become a medium 
and long term issue. This is not exclusive for Portugal, since other studies conducted in 
different countries show a similar problem: population ageing. 
Several studies have been developed over time. Greinacher, Fendrich, Alpen and 
Hoffmann (2007) studied the impact of demographic changes on the blood supply in 
Mecklenburg-West Pomeria (Germany); the impact for safe blood supply attending 
demographic changes was studied by Greinacher et al. (2010); Ali, Auvinen and 
Rautonen (2010) researched the global challenge for blood services due to the ageing of 
the population; Borkent-Raven et al. (2010) performed a study on demographic changes 
and the prediction of blood supply and demand in the Netherlands similar to what 
Jökulsdóttir (2013) elaborated for the Iceland population. In 2011, Greinacher et al. 
(2011) continued their work on this topic and studied the implications of demographics 
on future blood supply in a population-based cross-sectional study. Recent studies are 
focusing on the donors: estimation of the size of potential blood donor pool (Lucky et al., 
2014); demography and patterns of donation (Lattimore et al., 2015); donors return 
behaviour (Evans and Ferguson, 2014; Kheiri and Alibeigi, 2015; Lownik, Riley, 
Konstenius, Riley and McCullough, 2012; Ziegler et al., 2015). 
The Portuguese Government took the Memorandum of Understanding established 
with the European Union, European Central Bank and the International Monetary Fund 
committed to improve the performance and accuracy in the management of hospitals in 
the National Health Service (NHS) through an optimum and efficient use of available 
resources and simultaneously guaranteeing the right constitutional health protection. For 
this purpose, the Minister of Health through the Order No. 10601/2011, published in the 
Republic Diary No. 162, 2nd Series of August 24 2011, established the creation of a 
Technical Group for the Hospitals Reform whose objective was the proposal of a set of 
measures for the reorganization of the hospital network through an integrated and rational 
vision of the health system in order to guarantee the access and quality improvement of 
health services; hospital efficiency improvement; economic and financial sustainability 
insurance; improvement of governance and performance of professional service 
hospitals; and strengthen the role and duty of information to citizens (Grupo Técnico 
Reforma Hospitalar, 2011). 
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According to the Grupo Técnico Reforma Hospitalar (2011), the performance of 
Business Public Entity (EPE) hospitals shows a negative operating result of € 395,4 
million and € 5,184 million of receipts. The receipts have resulted almost entirely from 
the € 4,781 million corresponding to the amount of program contracts with the Portuguese 
State. The resulting net income was negative, ascending to € 322,1 million. This value 
will be added to previous years Retained Earnings, which exhibit accumulated losses of 
€ -1449,2 million. The reform of the hospitals is imperative and urgent. It is urgent to 
create an organization not only more in line with the expectations of citizens and but also 
more competitive, innovative and humanized, where freedom of choice is possible, and 
the competitiveness among hospitals plays a role as an induction factor of a better 
performance. Financial flows should gradually compensate and reward efficiency and 
quality (Grupo Técnico Reforma Hospitalar, 2011). 
 
1.1. The hospital context in the Algarve region 
Before 2013, the Algarve region had two public hospitals to serve its population. 
The localization of one is in the Windward area - Hospital Centre of the Western Algarve, 
EPE and of the other is in the Leeward zone - Faro Hospital, EPE. In 2013, as a 
consequence of the policy measures that Portugal had been going through since 2011, 
along with the economic and financial context of the country, it became urgent to 
rationalize and readjust facilities, achieve immediate cost savings, create synergies, and 
get greater efficiency and effectiveness in the operation of the hospital care objectives. 
For these reasons the Portuguese Government was impelled to merge the two hospitals. 
In May 17th, 2013, the Decree-law No. 69/2013 of the Ministry of Health was published 
in the Republic Diary, creating the Algarve Hospital Centre (CHA), by merging the Faro 
Hospital, EPE and the Hospital Centre of the Western Algarve, EPE. This measure took 
effect in July 1st, 2013 (Diário da República, 2013). 
 Studies that were carried out between 2011 and 2013 by the Central 
Administration of the Health System, IP (Public Institution), the Technical Group for 
Hospital Reform, the Regulatory Healthy Entity and the Regional Health Administrations 
allowed the classification of NHS institutions and hospital services in four groups: Group 
I, Group II, Group III and Group IV, according to the nature of their responsibilities, 
valence frame and hospital network positioning. The hospital network is classified in 
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groups according to the complexity of the response offered to the population, ensuring 
proximity and hierarchy of healthcare. The CHA belongs to group II which complies with 
the following:  
 
“…Medical and surgical valences of Group I, plus the valences of 
ophthalmology, pulmonology, cardiology, rheumatology, gastroenterology, 
nephrology, haematology clinic, infectiology, medical oncology, 
neonatology, immuno-allergy, obstetrics/gynaecology, dermatology, 
venereology, otorhinolaryngology, urology, vascular surgery, neurosurgery, 
pathology, nuclear medicine and neuroradiology…”, “…Remaining valences 
are defined according to minimum served population, maps function referral 
and national distribution of medical and surgical specialties…” and “…does 
not exercise the valences of clinical pharmacology, medical genetics, 
paediatric cardiology, cardiothoracic surgery and paediatric surgery”(Diário 
da República, 2014: 2365). 
 
 The high population concentration in the coastal line is a result of strong 
seasonality and the strengthening and diversification of the tourist offer are specific 
aspects of Algarve that deserve special attention and influence the socio-demographic 
context of the region (Centro Hospitalar do Algarve, 2014). The CHA is based in Faro 
city and currently is the only public health care hospital in the Algarve region. It consists 
of a set of 3 hospitals (located in Faro, Portimão and Lagos) and 4 emergency basic units 
(located in Vila Real de Santo António, Loulé, Albufeira and Lagos) that provides direct 
assistance to the entire population of the Algarve. According to provisional data of Census 
2011 there is a resident population of about 450 000 inhabitants, which can increase by 
three times in summer. This hospital has very specific characteristics in the universe of 
entities of the NHS, which include, among others, the distance to the reference entities 
located in Greater Lisbon (round trip is around 600 km); the distance between the three 
hospitals that make up CHA: Faro/Portimão: 70 km, Faro/Lagos: 90 km and 
Portimão/Lagos: 20 km; cost of installed capacity to respond in emergency rooms (Faro: 
Multipurpose Urgency and Portimão: Medical-Surgical Emergency) by virtue of the 
increasing flows related to the peculiarity of the Algarve being primarily a touristic area 
(Centro Hospitalar do Algarve, 2014). 
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1.2. Resident Portuguese population projections 2012-2060 
According to INE (2014b), we will witness a decline in population from 10.5 
million people in 2012 to 8.6 million in 2060, and structural changes in population leading 
to a strong demographic ageing. These calculations take into account a set of demographic 
assumptions about fertility, mortality and international migration. Four projection 
scenarios are generated: low projection scenario - combines the pessimistic assumptions 
for fertility, central for mortality and pessimistic for migration; central projection scenario 
- associates the cases of central trend for fertility and mortality and optimistic for 
migration; high projection scenario - combines the chances of optimistic evolution for 
fertility, mortality and migration; scenario without migration - setting identical to the 
central projection scenario, but contemplating the possibility of non-occurrence of 
migration (Figure 1.2 and Table 1.2).  
 
 
Figure 1.2 Age pyramid, Portugal, 2012 (estimated) and 2060 (projections scenarios)  
 
 
 
 
 
 
 
Source: INE (2014b) 
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Table 1.2 Portugal and Algarve, 2012 (estimated) and 2060 (projection) 
P
o
rt
u
g
a
l 
a
n
d
 
N
U
T
S
 I
I 
Projection 
scenarios 
Total Population Population 0-14 years Population 15-64 years 
Population 65 and 
older 
2012 2060 2012 2060 2012 2060 2012 2060 
No. 
P
o
rt
u
g
a
l 
Low 
10 487 289 
6 346 726 
1 550 201 
587 623 
6 904 482 
3 030 165 
2 032 606 
2 728 938 
Central 8 575 339 992 556 4 540 143 3 042 640 
High 9 223 617 1 165 090 4 714 540 3 343 987 
without 
migration 
7 856 281 833 925 4 059 331 2 963 025 
A
lg
a
rv
e 
Low 
444 390 
319 930 
68 943 
33 615 
287 313 
162 837 
88 134 
123 478 
Central 454 489 58 818 252 910 142 761 
High 486 967 68 857 261 876 156 234 
without 
migration 
345 651 38 673 181 930 125 048 
 Source: INE (2014b) 
As we can see in the Figure 1.2 for the four scenarios projected for 2060, the age 
structure will change its shape, making it tighter in the age groups under 65 and will 
increase its distribution at the age groups of 65 years old or more. Table 1.2 reveals the 
number for each created scenario, for three age groups: 0-14 years old, 15-64 years old 
and 65 and more years old. It is interesting to observe that in age group 65 and more years 
old, forecasts will always exceed the real number observed in 2012. In the worst scenario 
(Low) this population will increase 40.0% and in the best scenario (High) it will increase 
77.0%.  
 
1.3. Objectives and structure of the dissertation 
Given the general picture of the region in the last section, the main objectives of 
this dissertation are the following: to elaborate projections for population ageing of 
Algarve in the year 2060 (four scenarios); to identify opportunities in order to increase 
the promotion and the number of homologous donations; and to assess the hospital 
services needs versus the availability of blood components. 
For this purposes, the dissertation is structured as follows: after the introduction, 
chapter 2 reports the literature review, chapter 3 mentions the data collection and 
methodology framework, chapter 4 presents the results and discussion and chapter 5 
presents the conclusion of the work. 
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Chapter 2. LITERATURE REVIEW 
2.1. Previews studies 
 Greinacher et al. (2007) analysed how demography will determine future blood 
demand and supply in Mecklenburg-West Pomerania (Germany). The population of the 
main area of influence of the University Hospital Greifswald (415 000 inhabitants), based 
on 1-year age groups provided by population register, was projected for the year 2015. 
This projection was based on 2002 rates assuming constant mortality rates and migration 
patterns. Donors and recipients data from 1996 through 2004 were extracted from the 
database of the Department of Transfusion Medicine. Until 2015, the increase in the older 
population will result in an increase of blood transfusions from 11.8% to 13.9%. 
Assuming a similar motivation to donate blood as in 2004, the decrease in the younger 
population will cause a 27.5% to 32.6% decrease of blood donations until 2015. The 
increased demand for blood coincides with a significant reduction in blood donations. 
From 2008 the shortfalls will grow from 32.0% to 35.0% of the total demand in 2015 in 
the studied area. The demographic trends will affect many regions in Europe similarly. 
Coordinated efforts will be required to prevent blood shortages based on these 
demographic trends in western countries. 
 Greinacher et al. (2010) studied the impact of these demographic changes on 
future blood demand and supply since they believed that data on blood recipients and 
donors were sparse and unconnected. They first reviewed and summarized studies on the 
effect of the demographic change on blood supply and demand, realizing that the 
demographic trends will affect many regions in the Western world similarly. Then, in 
their second part of the review they report an overview of the methodological approaches 
to obtain data on the socio demographic background of the blood donor population. They 
conclude that there was a considerable risk that the demand to blood donation ratio was 
changing in a way which will threaten the supply of sufficient amounts of RCC. They 
also conclude that all available data supported the assumption that the demographic 
change will likely be one of the biggest challenges for transfusion medicine in the next 
decades. 
 Ali et al. (2010) performed a study in Finland in which the transfusion registry 
data suggested some alarming signals and future challenges as a result of the population 
ageing. Computerized data collection was performed on all potentially transfused patients 
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in Finland (approximately 70.0% of all blood usage) and it was simulated the use of RCC 
according to the Finnish practice on different age groups but crossing with the population 
demographics from other countries. The Finnish data revealed a marked increase in RCC 
consumption in older patients. The authors concluded that a large part of the variation in 
RCC use per capita is explained by the age distribution of the different populations and 
not by the different nationalities and regional treatment policies and protocols in use. If 
current efforts are not enough to serve the changing population demography and if higher 
demands for blood products cannot be attained, then there is a need to consider 
unprecedented measures such as reversing certain donor deferrals or even exporting blood 
from country to country. 
 For Borkent-Raven et al. (2010) from the Netherlands, the ageing of the general 
population determines an increase in the use of blood products. They developed three 
mathematical models: the first was a demand model that assumes that the average number 
of transfusions per inhabitant/age/gender is constant; the second was a demand model that 
incorporated observed changes in clinical blood use over time; the third was a donation 
model developed to forecast future RCC supply. The supply of whole blood donations 
estimation was calculated taking into account the annual donor retention, the recruitment 
rates and the mean number of donations per donor and per year. The first model predicted 
an increase of 23.0% in RCC demand from 2008 to 2015. The second model predicted a 
decrease of RCC demand by 8.0% over the same period. The third model predicted that 
RCC supply would closely follow the demand as predicted by the second model. They 
concluded that despite of the ageing of population, RCC demand might not increase so 
much as indicated in other studies. Nevertheless, the observed downward trend in donor 
recruitment in the Netherlands should be stopped in order to maintain a sufficient RCC 
supply. 
 Greinacher et al. (2011) analysed the impact of the demographic change on future 
blood demand and supply in the German federal state Mecklenburg-Pomerania by 
performing a population-based cross-sectional study. For all in-hospital transfused RCC 
(95 477 RCC units), the characteristics of the patient and the blood donors (118 406 blood 
donations) were taken. Population data were used to predict blood demand and supply 
until 2020. By 2020 the increase of population of those aged 65 years or more (+26.4%) 
would be followed by a drop in the potential donor population (18-68 years; -16.1%). 
Assuming stable rates per age group until 2020, the demand for in-hospital blood 
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transfusions would increase by approximately 25.0% (24 000 RCC units), while blood 
donations would decrease by approximately 27.0% (32 000 RCC units). The resulting 
predicted shortfall would be 47.0% of demand for in-hospital patients (56 000 RCC 
units). Validation using historical data (1997-2007) showed that the model for the RCC 
demand prediction had a deviation of only 1.2%. Demographic changes are particularly 
pronounced in former East Germany, but by 2030 most European countries will face a 
similar situation. The decrease of younger age groups requires an increase of blood 
donation rates and interdisciplinary approaches to reduce the need for transfusion to 
guarantee sufficient blood supply. Demography is a major determinant of future 
transfusion demand. All efforts should be made by Western societies to systematically 
obtain data on blood donors and recipients in order to develop strategies to meet future 
blood demand. 
 Lownik et al. (2012) through the knowledge, attitude and practice (KAP) surveys, 
came to the understanding of the factors that influence blood donation as well as the basis 
for communication and donor mobilization strategies. A search of publically available 
databases was conducted, and studies with the following characteristics were selected: (1) 
the study was a knowledge, attitude and practice or KAP plus behaviour survey; (2) the 
subject of the survey was blood donation; (3) the survey was performed between 1995 
and 2011; and (4) the survey was performed in countries classified as emerging and 
developing countries by the International Monetary Fund. Eighteen KAP studies were 
conducted in seventeen developing countries. There were considerable differences in the 
structure, behaviour and population surveyed for KAP studies. The common following 
themes emerged: misinformation about blood donation, fear of blood donation, 
willingness to donate for family and friends, concern about selling blood and a failure to 
transfer positive attitudes into actual blood donation.  
 Jökulsdóttir (2013) performed population-based studies on demographic 
influences regarding blood supply and demand in Iceland. The research methods 
consisted of an extensive review of relevant literature on demographic changes, combined 
with the collection and analysis of empirical data (Icelandic Blood Bank and the Bureau 
of Statistics in Iceland) using a population-based cross-sectional research. The conclusion 
was that demographic changes would affect both supply and demand of blood products 
in Iceland in the future. 
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 Evans and Ferguson (2014) took the theories of altruism from psychology, 
economics and evolutionary biology to help to inform both our understanding of the 
altruistic motives of blood donors and recruitment intervention strategies. A cross-
sectional survey (time 1), with a 1-month behavioural follow-up (time 2), was designed 
to assess theoretically derived constructs from psychological, economic and evolutionary 
biological theories of altruism. Theory of planned behaviour (TPB), variables and co-
operation were also assessed at time 1 and a measure of behavioural co-operation at time 
2. Five theoretical dimensions of altruism (impure altruism, kinship, self-regarding 
motives, reluctant altruism and egalitarian warm glow) were identified through factor 
analysis. Donors can be differentiated from non-donors through these five altruistic 
dimensions (donors scored higher on impure altruism and reluctant altruism), showed 
incremental validity over TPB constructs to predict donor intention and predicted future 
co-operative behaviour. These findings show that altruism in the context of blood 
donation is multifaceted and complex and does not reflect pure altruism. This has 
implication for recruitment campaigns that focus solely on pure altruism. 
 Lattimore et al. (2015) performed a study in England and North Wales that 
included all first-time and regular blood donors whose blood donations had been collected 
by the NHS Blood and Transplant during 2010 and 2011. Factors associated with new 
blood donors returning within 6 months were analyzed using multivariate logistic 
regression. The majority (87.9%) of them were white British; 5.5% were unknown; 3.4% 
white Irish or white other; 3.2% composed of all other ethnic groups. The median ages of 
new and regular donors in 2010 were 28 and 45 years old, respectively, compared to 29 
and 47 years old in 2011. Rates of donation varied with ethnicity, ranging from 1.6% 
among Asian Bangladeshi origin, compared to 22.1% among white British origin. 
Approximately two in five (38.4%) new blood donors returned within 6 months and were 
more likely to be male and of white ethnicity. They concluded that blood supply is 
impacted by numerous factors, including population ageing and an increase in emigrant 
communities with low donation rates. It is therefore critical that changes within the blood 
donors and wider population be monitored for the gathering of information regarding 
donor recruitment and retention strategies. 
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2.2. Blood substitutes 
Blood products are indispensable since there is no synthetic alternative available 
and they must be obtained from human donors (Bönig, Schmidt and Hourfar, 2012; Evans 
and Ferguson, 2014; Kheiri and Alibeigi, 2015; Páez et al., 2013). 
The increasing number of elective surgeries associated with the small but still 
remaining risk of transmission of blood-borne pathogens stimulate scientists to develop 
a synthetic substitute for human blood, more specifically for development of a red blood 
cell substitute. The attempt to develop a viable blood substitute spans from more than 
seven decades. These efforts have essentially focused on the ability of red blood cells to 
carry oxygen. Therefore, most of the products that are in advanced-phase clinical trials 
are derivatives of hemoglobin and are known as hemoglobin-based oxygen carriers. At 
the present time, no oxygen-carrying blood substitutes are approved for use by the US 
Food and Drug Administration. This fact highlights not only the challenges that exist in 
formulating an effective blood substitute but also the immense potential that exists in this 
field (Grethlein, 2015).  
 
 
2.3. Impact of demographics on blood supply and demand  
 Greinacher et al. (2007) defined blood supply as a transfer of blood from a 
population of donors to a population of recipients, where the donor population consists 
primarily of young, healthy individuals, and the patients requiring blood transfusion are 
mostly elderly. There is an inherent concern with the demographic changes in developed 
countries where the increase of the elderly population leads to a higher demand for blood 
components (Ali et al., 2010; Borkent-Raven et al., 2010; Lattimore et al., 2015; Lucky 
et al., 2014; Seifried et al., 2011). Bönig, Schmidt and Hourfar (2012) also defend that 
blood components consumption needs will grow permanently, following the medicine 
development and the increase of the average life expectancy. In other words, people will 
live longer, but will also need more health treatments (Ali et al., 2010; Santana, 2000). 
High complexity therapeutic procedures in areas such as haematology-oncology or 
cardiovascular surgery are examples of interventions done majority in aged 
population(Al-Khabori, Al-Riyami, Mukaddirov and Al-Sabti, 2014; Greinacher et al., 
2007; Seifried et al., 2011). 
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A suitable blood components supply is only possible when the number of 
homologous donations and transfusion of blood components are balanced (Greinacher et 
al., 2010; Greinacher et al., 2007; Masser, White, Hyde and Terry, 2008). Health systems 
rely on safety treatments and effectiveness in order to maintain their main goals. Blood 
donations are preceded of a knowledge, attitude and practice survey (Evans and Ferguson, 
2014; Lownik et al., 2012).  
On January 27th  2003,  the European Union adopted the Directive 2002/98/EC on 
setting standards of quality and safety for the collection, testing, processing, storage and 
distribution of human blood and blood components (EDQM, 2015). 
In Portugal, the Decree-law No. 185/2015 proceeds to the second amendment to 
the Decree-law No. 267/2007, from July 24th 2007, transposes the European Parliament 
and the European Council Directive No. 2014/110/EC, January 27th 2004 and changes 
the Directive No. 2004/33/EC (EUR-Lex) from the Commission, March 22nd 2004, 
relatively to the homologous donations criteria for temporary suspension of blood donors, 
into an internal juridical order. According to the aforementioned Decree-law, the 
Portuguese Blood and Transplantation Institute (IPST), IP, has the mission to monitor the 
transfusion medicine activity and ensure the availability and accessibility of safe and 
effective blood and blood-quality components at a national level. The IPST coordinates, 
guides and regulates all activities related to blood transfusion, and plays an important role 
in the definition of national policies for the Transfusion Medicine (Diário da República, 
2015). Also the Decree-law No. 39/2012 makes reference to IPST, IP, as an institution 
that ensures and regulates, at a national level, the activity of Transfusional Medicine and 
Transplantation and ensures that the donation, collecting, testing, processing, 
preservation, storage and distribution of human blood, blood components, organs, tissues 
and cells of human origin are made according to specific requirements. This Decree-law 
establishes the creation of a national blood transfusion network that safeguards the access 
to blood components whenever necessary (Diário da República, 2012) 
Under this legislation, blood donors that perform voluntary donations, also known 
as altruist and homologous, must fulfil minimal established criteria such as a minimum 
weigh of 50 kg, be healthy and aged 18 or over. Details are shown in Table 2.1. 
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Table 2.1 Translation of Appendix VII of Decree-law No. 185/2015 
Age … 18 to 65 years.  
 17 to 18 years……………… Unless legally considered as a minor, or 
by consent from parent or legal 
guardian in accordance with the 
provisions of law.. 
 First time donors with age above 
60 years………...…… 
According to the criteria  of the blood 
establishment physician 
 More than 65 years………… Under authorization of the blood 
establishment physician, granted 
annually.  
Source: Diário da República (2015) 
 
The frequency of donation is also regulated. Males can donate blood every 3 
months (maximum of 4 donations per year) and females every 4 months (maximum of 3 
donations per year). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
16 
  
Chapter 3. DATA COLLECTION AND METHODOLOGY FRAMEWORK  
This chapter describes the methodology used in this study to collect the data and 
perform statistical analysis to attain the research objectives. Data description is an 
essential part of any research project, since familiarity with the data, searching for outliers 
and verification of assumptions for statistical tests are of outmost importance (Whitley 
and Ball, 2002). 
Descriptive statistics is concerned with the organization, condensation and 
presentation of information set in order to quantitatively describe the subject of study 
(Coelho, Cunha and Martins, 2008; Sheskin, 2007). Descriptive statistics is used here to 
characterize donors and patients. 
Statistical inference includes a number of techniques to make inferences about an 
unknown characteristic of the population. It allows the estimation of characteristic values 
of the population of interest and the performance of tests that validate, or not, a formulated 
hypothesis about values or shape of the variable distribution (Coelho et al., 2008; Sheskin, 
2007). Inferential statistics are used for forecasts. 
This study is therefore a quantitative research. A quantitative research is an 
objective, formal and systematic process where numeric data are used to collect 
information about the world. This research method is used to describe the variables, to 
examine and establish cause-effect relationships between them (Burns and Grove, 2005). 
It is the most suitable approach for this study, since there is a concern about the current 
and the future number of blood donors, while taking into consideration the Algarve 
population forecasts for the next years. 
Regarding the Portuguese population demographics and projections, data were 
extracted from the Portuguese Official Statistics Institute (Attachment A). 
A statistical analysis with SPSS (Statistical Package for the Social Sciences) 
software (version 21) was applied for donors and receptors/patients data analysis (Pereira, 
2006). 
 
3.1 Data description and sources 
 The research work and data collection were taken in the region of Algarve at the 
CHA. The study and data collected span a time period of 5 years, from January 2010 to 
17 
  
December 2014. Data from homologous blood receptors/patients characterization and 
RCC consumption were collected through the use of the software Application System of 
Blood Information (ASIS). Each transfused RCC unit was considered as one event. INE 
provided all the information, historical and projected, from Algarve population.  
 In the period of study, the blood donations in this facility oscillated from 13 000 
to 15 000 whole blood units/year. The population of Algarve and the number of donations 
in this region represent approximately 4.0% of the Portuguese population and donations 
(Sousa et al., 2014).  
 
3.1.1 Donors characterization 
During this 5 years study CHA had a registration of 8 450 first time donors, 10 
151 donors who had already donated in other institutions and 50 598 regular donors 
making a total of 61 442 donors (Figure 3.1). Is important to note that not all of these 
donors were eligible to donate blood, some might have been temporary or permanent 
deferred if they did not comply with the requirements set up in the Decree-law No. 
185/2015. 
Figure 3.1 Homologous donors in CHA from 2010-2014 
 
Source: ASIS (2015); author´s calculation 
Donors who gave blood for the first time along with donors who did it for the first 
time in CHA had a slight increase from 2010 to 2011 and since then, they have been 
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falling slightly until 2014. The total number of homologous donors decreased from 2010 
to 2014 except in 2012 when the number of registered donors reached its maximum. 
 Featuring the donor population by nationality, 7.6 % are foreigners and their 
geographic distribution is reported in Table 3.1: 
 
Table 3.1 Foreign donor population origins distribution by geographic area from 2010 to 2014 
Geographic area 2014 2013 2012 2011 2010 
Central Africa 0 2 5 3 2 
North Africa 1 4 3 5 8 
South Africa 4 6 16 19 8 
Western Africa 44 59 64 69 42 
East Africa 16 23 33 15 11 
Central America 0 1 1 0 0 
North America 7 9 9 13 15 
South America 302 313 338 431 399 
South Asia 2 9 3 8 2 
Southeast Asia 4 3 3 2 0 
West Asia 0 0 2 1 0 
East Asia 0 0 0 0 3 
Western Europe 154 178 195 219 156 
Eastern Europe 199 187 183 193 179 
Middle East 0 1 2 3 2 
Caribbean 1 3 5 2 4 
Australia 2 3 1 1 1 
Bouvet Island 0 0 0 1 0 
Cabo verde 22 26 25 37 22 
Sao Tome and Principe 5 6 4 5 5 
Not identified 46 50 60 67 59 
Total 809 883 952 1094 918 
Source: ASIS (2015); author´s calculation 
 
It can be identified in the above table three major geographic areas: South 
America, Western Europe and Eastern Europe. In South America 97.0% of donors are 
from Brazil. In Western Europe 39.4% of donors are British, 20.3% French and 11.1% 
Spanish. In Eastern Europe 44.0% of donors are from Ukraine, 31.8% from Romenia and 
12.5% from Moldavia. The foreign donor population shows a slight decrease during the 
last three years of the period of study. 
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Regarding gender, we can observe that male donors donate more often than 
women (Figure 3.2). However, we have to take into consideration that males are allowed 
to donate 4 times per year while females can only do it 3 times per year, owing to the fact 
that the replacement of iron levels in childbearing age women is slower due to losses 
during the menstrual cycles and/or pregnancies, associated with an inherent lower blood 
volume. 
Figure 3.2 Donors gender in CHA from 2010-2014 
           
Source: ASIS (2015); author´s calculation 
 
 With regard to the age range of donors, we can conclude that the age group of 
25 to 44 years old is the one that most contributed to blood donation in Algarve. Donations 
from the youngest age group (18-24) reached its peak in 2012 (16.8%) but it has been 
decreasing since then. In the last two years of the study, distribution of donors by age 
group has remained constant, whereas donations in the 25-44 year old group are the 
highest ones, followed by donations in the 45-65 year old group and finishing by the 18-
24 year old group who had the lowest donations rate (Table 3.2 and Figure 3.3). 
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Table 3.2 Donations rate from 2010-2014 CHA 
 Donors 
  Age group  Donors No Donations No 
2
0
1
4
 
18-24 956 
13 336 25-44 5 120 
45-65 3 431 
2
0
1
3
 
18-24 1 128 
14 279 25-44 5 620 
45-65 3 500 
2
0
1
2
 
18-24 3 188 
15 201 25-44 9 977 
45-65 3 803 
2
0
1
1
 
18-24 1 911 
15 987 25-44 6 954 
45-65 2 944 
2
0
1
0
 
18-24 1 423 
15 607 25-44 8 688 
45-65 5 567 
         Source: ASIS (2015); author´s calculation 
 
 
Figure 3.3 Donors age rate in CHA from 2010-2014 
 
Source: ASIS (2015); author´s calculation 
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3.1.2 Patients characterization 
 
3.1.2.1 Blood transfusion 
 
RCC transfusion is evaluated in three age groups: 0-14, 15-64 and over 65 years 
old as demonstrated in Table 3.3.  
Table 3.3 RCC transfusion from 2010-2014 in CHA 
 
 
 
 
 
 
 
 
 
 
 
 
           Source: ASIS (2015); author´s calculation 
 
For all age groups the number of transfused patients reached its peak in 2011. 
The age group 0-14 had an increase in the transfusion of RCC from 2010 until 
2014, except in 2013. The age group 15-64 had an increase in the transfusion of RCC in 
2010, 2011 and 2014, decreasing in 2012 and 2013. The age group over 65 had an increase 
in the transfusion of RCC from 2010 to 2012, decreasing in 2013 and 2014. This last 
group represented 72.0% of all transfusions in 2010 and 2011, 73.0% in 2012 and 2013 
and 71.0% in 2014.  
 
 Patients 
  Age group  Patients (No) RCC (No)  
2
0
1
4
 
0-14 55 204 
12 889 15-64 1 046 3 536 
≥ 65 2 676 9 149 
2
0
1
3
 
0-14 41 143 
13 091 15-64 1 004 3 426 
≥ 65 2 729 9 522 
2
0
1
2
 
0-14 72 216 
13 507 15-64 1 001 3 457 
≥ 65 2 780 9 834 
2
0
1
1
 
0-14 79 193 
13 545 15-64 1 063 3 665 
≥ 65 2 820 9 687 
2
0
1
0
 
0-14 65 153 
13 043 15-64 943 3 467 
≥ 65 2 681 9 423 
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3.1.2.2 Blood transfusion by medical areas in CHA 
 
For a RCC to be transfused it is required to fulfil a request, where several 
information such as identification of the patient, diagnosis, haemoglobin values, amount 
and type of component, must be provided. Services were grouped in fourteen groups 
according to the tasks performed and areas of intervention. Table 3.4 shows the 
distribution in CHA from 2010-2014: 
 
Table 3.4 RCC distribution in the main services in CHA from 2010-2014 
Medical areas 2014 2013 2012 2011 2010 Total 
Cardiology 30 55 33 45 21 184 
Outpatient visits 788 792 501 51 2 2 134 
Day-care hospital 556 589 656 719 464 2 984 
Emergency 3 871 4 405 4 235 4 417 4 574 21 502 
Gynecology and obstetrics 509 501 479 596 571 2 656 
Medicine 1 774 1 668 1 679 1 572 1 449 8 142 
Neonatology / Pediatrics 197 133 187 236 173 926 
Nephrology 603 547 626 606 578 2 960 
Oncology 698 683 766 819 849 3 815 
Operating room 486 547 490 583 616 2 722 
Orthopedics 811 885 836 943 939 4 414 
Pediatric emergency 41 36 33 27 20 157 
Surgery 1 148 1 196 1 369 1 487 1 494 6 694 
Urology 352 365 408 459 429 2 013 
Total 11 512 12 037 11 890 12 101 11 750  
          Source: ASIS (2015); author´s calculation 
 
The five services that have a higher use of RCC are oncology, orthopaedics, 
surgery, medicine and emergency (Figure 3.4). It is important to notice that 99.0% of the 
transfused RCC in the day-care hospital correspond to haematology outpatients. 
Table 3.3 represents all the transfusions performed by CHA and exhibits a higher 
number of RCC than Table 3.4, given that this last one only represents the main services 
it does not include private hospitals requests. 
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Figure 3.4 The five more RCC consumer services in CHA from 2010-2014 
 Source: ASIS (2015); author´s calculation 
 
3.1.3 Donors versus Patients 
 It can be noticed that the number of donations has always remained higher than 
the number of the transfused RCC. However it is observed that from 2010 to 2014, there 
is a declining trend, which in a medium or long term future can make this number quite 
similar to the requested RCC. We have 83.6% in 2010, 84.7% in 2011, 88.9% in 2012, 
91.7% in 2013 and 96.7% in 2014 blood donations that were transfused (Figure 3.5). 
 
Figure 3.5 Donations versus transfusions in CHA 2010-2014 
 
                                Source: ASIS (2015); author´s calculation 
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3.2. Methodology framework 
It is important to verify whether the distribution of the forecast and the real 
consumption of RCC in 2013 are significantly different, in order to validate the 
forecasting model. Like in other studies, the Wilcoxon matched-pairs signed-ranks test is 
the most suitable test for this purpose (Greinacher et al., 2011; Jökulsdóttir, 2013).  
The Wilcoxon matched-pairs signed-ranks test (Wilcoxon, 1945) is a 
nonparametric procedure in which there is the hypothesis testing situation involving a 
design with two dependent samples, and it is applied in metric or ordinal data  (Coelho et 
al., 2008; D´Hainaut, 1997; Sheskin, 2007). This test is the distribution-free analogue of 
the t test for related samples (David Howell, 2013). It requires that each n pairs of matched 
subjects has two interval/ratio scores where each score obtained under one of the two 
experimental conditions (Condition 1 and Condition 2). A difference score is computed 
for each pair of matched subjects by subtracting subject´s score in Condition 2 from his 
score in Condition 1. The hypothesis evaluated with the Wilcoxon matched-pairs signed-
ranks test is whether or not in the underlying populations represented by the 
samples/experimental conditions, the median of the difference scores equals zero 
(Sheskin, 2007). The null hypothesis tested by the Wilcoxon matched-pairs signed-ranks 
test is that the two sets of paired observations come from populations having the same 
distribution. The alternative hypothesis states that the two sets of paired observations 
come from populations having different distributions (David Howell, 2013; Russo, 2003; 
Sheskin, 2007). The Wilcoxon matched-pairs signed-ranks test is based on the following 
assumptions: a) the sample of n subjects has been randomly selected from the population 
it represents; b) the original scores obtained for each of the subjects are in the format of 
interval/ratio data; and c) the distribution of the difference scores in the populations 
represented by the two samples is symmetric about the median of the population of 
difference scores (Sheskin, 2007). 
 
3.2.1 Outliers 
An outlier is a score in a set of data which is so extreme that, by all appearances, 
it is not representative of the population from which the sample is ostensibly derived 
(Sheskin, 2007). Any data analysis requires special attention to outliers and their inclusion 
or exclusion of the statistical analysis should be considered (Coelho et al., 2008). 
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When a data set has outliers, variability is often summarized by a statistic called 
the interquartile range (IQR), which is the difference between the first and third quartiles. 
The first quartile, denoted Q1, is the value in the data set that holds 25.0% of the values 
below it. The third quartile, denoted Q3, is the value in the data set that holds 25.0% of 
the values above it. The quartiles can be determined following the same approach that we 
use to determine the median, but we now consider each half of the data set separately. 
The interquartile range is defined by Q3-Q1 (Chris Spatz, 2010; David Howell, 2013)  
Outliers are values below Q1-1.5(Q3-Q1) or above Q3+1.5(Q3-Q1) or 
equivalently, values below Q1-1.5 IQR or above Q3+1.5 IQR (Marôco, 2010; Murteira, 
Ribeiro, Silva and Pimenta, 2002; Naiman, Resenfeld and Zirkel, 1996).  
The IQR method was applied on data collected from ASIS referent to patients for 
each year analysed in this study: 2010, 2011, 2012, 2013 and 2014 and from the ages 0 
to 99 years old (Appendix 1).  
For example, here are the calculations for the year 2010 and, as it can be observed, 
there are no outliers (Tables 3.5; 3.6 and 3.7): 
 
Table 3.5 Percentiles calculation for year 2010 
 
Percentiles 
5 10 25 50 75 90 95 
Weighted Average 
(Definition 1) 
RCC .00 2.00 24.00 97.00 223.00 358.00 403.00 
Tukey's Hinges RCC   24.00 97.00 216.00   
Source: SPSS (2015); author´s calculation 
 
Table 3.6 Interquartile Range calculation for year 2010 
 
 
 
 
            Source: Marôco (2010); Murteira et al. (2002); Naiman,  
            Resenfeld and Zirkel (1996); author´s calculation 
  
 
Upper fence:  
Q3 + 1.5 * IQR = 216 + 1.5 * 192 = 504.00 
Lower fence:  
Q1-1.5*IQR = 24 – 1.5 * 192 = - 264.00 
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Table 3.7 Extreme values calculation for year 2010 
 
 
 
 
   
 
 
 
 
 
   Source: SPSS (2015); author´s calculation 
 
For the studied years, five outliers have been detected. They have been excluded 
from the calculation process: two in 2011, one in 2012 and two in 2013 (Table 3.8).  
 
Table 3.8 Outliers calculation for the years 2010, 2011, 2012, 2013 and 2014 
Year Median 
1st 
Interquartile 
3rd 
Interquartile 
Interquartile 
range 
Lower 
limit 
Upper 
limit 
Outliers 
No 
2010 97,00 24,00 216.00 192,00 -264,00 504,00 0 
2011 99,00 30,00 202,50 172,50 -229,00 461,00 2 
2012 79,00 31,50 210,00 178,50 -236,00 478,00 1 
2013 77,00 18,50 204,50 186,00 -261,00 484,00 2 
2014 86,00 31.00 237,00 206,00 -278,00 546,00 0 
      Source: SPSS (2015); author´s calculation 
 
3.2.2 Validation of the projection model  
To validate the projection model, data from 2010 was used to project demand for 
2013. Then the values for demand obtained from this previous projection and the real 
ones in 2013, available from the collected data, were compared. The number of transfused 
RCC was split into three age groups: 0-14; 15-64 and over 65.  
Extreme Values 
 Case 
Number 
Value 
RCC Highest 1 99.00 427.00 
2 98.00 426.00 
3 97.00 424.00 
4 96.00 414.00 
5 95.00 403.00 
Lowest 1 5.00 0.00 
2 4.00 0.00 
3 3.00 0.00 
4 2.00 0.00 
5 1.00 0.00 
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The expression (3.1) is used to forecast data from 2010 to 2013 and it was 
replicated from the study of Borkent-Raven et al. (2010). First we calculate the RCC 
transfusion incidence by the average number of RCC distributed per inhabitant of Algarve 
per age groups (RCC transfusion incidence = Average of RCC transfusion 2010 / The 
number of inhabitants 2010). RCC demand is estimated by multiplying the RCC 
transfusion incidence (2010) with the number of inhabitants (2013): 
𝑅𝐶𝐶 𝑑𝑒𝑚𝑎𝑛𝑑 2013 =
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑅𝐶𝐶 𝑡𝑟𝑎𝑛𝑠𝑓𝑢𝑠𝑖𝑜𝑛𝑠 𝑖𝑛 2010
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑖𝑛ℎ𝑎𝑏𝑖𝑡𝑎𝑛𝑡𝑠 𝑖𝑛 2010
× 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑖𝑛ℎ𝑎𝑏𝑖𝑡𝑎𝑛𝑡𝑠 𝑖𝑛 2013 (3.1) 
This specific distribution was chosen due to the available data on the population 
of Algarve by INE in different age groups. The forecast for 2013 displayed an average 
demand of 119 RCC versus the 115 units (average) transfused in 2013 (Table 3.9): 
 
Table 3.9 Validation of the projection model for RCC in 2013 
 
                                                                                     
 
 
Sources: ASIS (2015) and INE (2015); author´s calculation 
 
After the projection of RCC demand for 2013 it is important to verify whether the 
(average) RCC projected population and real values in 2013 can be considered as 
belonging to the same population. Related-Samples Wilcoxon Signed Rank Test was 
performed in SPSS and the null hypothesis is retained (Table 3.10). 
Table 3.10 Related-Samples Wilcoxon Signed Rank Test for comparison of projected RCC demand 
(average) and the real demand of RCC (average) in 2013 
Hypothesis Test Summary 
 Null Hypothesis Test Sig. Decision 
1 
The median of differences between 
Projection for 2013 and Year 2013 equals 
0. 
Related-Samples 
Wilcoxon Signed Rank 
Test 
,109 
Retain the null 
hypothesis. 
Asymptotic significances are displayed. The significance level is ,05. 
Source: SPSS (2015); author´s calculation 
 
Year 2010 Projection for year 2013 Year 2013 
0-14 10,93 10,49 9,80 
15-64 68,59 66,30 66,23 
Over 65 269,23 280,97 267,70 
Total 348,73 357,76 343,73 
Average RCC 116,25 119,25 114,58 
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Therefore, we may conclude that, considering a significance level up to 10%, 
there is not enough evidence that the estimated value and the observed value belong to 
different populations. 
 
3.2.3 Forecast  
The forecasting procedure is used to calculate or predict a future value by using 
existing values. In our case, the predicted value represents a value of y for a given value 
of x. The x- variable represents the observed values of RCC, while the y- variable 
represents time (years). The forecasts are obtained after the estimation of expression (3.2) 
presented below, applying the Ordinary Least Squares estimation method: 
𝑦 = 𝑎 + 𝑏𝑥 + 𝑢,  (3.2) 
where 𝑎 and 𝑏 are parameters and 𝑢 is the error term, following a normal distribution 
with null mean and constant variance. 
The parameters' estimates are given by ?̂? = ?̅? − 𝑏?̅? and ?̂? =
∑(𝑥−?̅?)(𝑦−?̅?)
∑(𝑥−?̅?)2
 where ?̅? 
and ?̅? are sample averages (Sheskin, 2007).  
The results from 2013 (155 RCC) and the results from the projection for 2060 
(155 RCC) were used to obtain the estimates ?̂? and ?̂?: 
 
?̂? =
((115-135)(2013-2036,5))+((55-135)(2060-2036,5))
((115-155)2)+((155-135)2)
= 𝟏, 𝟏𝟕𝟓      
 
?̂? = 2036,5 − 1,175 ∗ 135 =  𝟏𝟖𝟕𝟕, 𝟖𝟖 
 
The estimated structure of equation (3.2), which is used for forecast purposes is 
expressed as:   
?̂? = 𝟏𝟖𝟕𝟕, 𝟗 + 𝟏, 𝟏𝟕𝟓𝒙. (3.3) 
 
Hence, we calculated the year in which the average transfusion exceeds the 
average of donors and donations. 
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Chapter 4. RESULTS AND DISCUSSION 
INE (2014b) reports the forecasts of the population of Algarve in 2060 in four 
different scenarios: low, central, high and without migration. The projection of RCC 
demand was carried out for the same scenarios by applying expression (3.3), in three age 
groups: 0-14, 15-65 and for ages over 65 years. The obtained results are shown in Table 
4.1. 
 
Table 4.1 CHA RCC demand (average) in four projection scenarios for 2060 
  0-14 years 15-64 years 65 and plus years Average RCC 
A
lg
a
rv
e 
2
0
6
0
 
Projection 
scenarios 
Population 
RCC 
demand 
(average) 
Population 
RCC 
demand 
(average) 
Population 
RCC 
demand 
(average) 
Population 
RCC 
demand 
(average) 
Low 33 615 4,84 162 837 37,90 123 478 368,35 106 643 137,03 
Central 58 818 8,47 252 910 58,86 142 761 425,88 151 496 164,40 
High 68 857 9,92 261 876 60,95 156 234 466,07 162 322 178,98 
without 
migration 
38 673 5,57 181 930 42,34 125 048 373,04 115 217 140,32 
Sources: ASIS (2015) and INE (2014); author´s calculation 
 
For the same scenarios and taking into account that the population of donors can 
only be aged between 18-65 years old, donors and donations demand were calculated for 
same age range and projected for 2060. Results are shown in Table 4.2. 
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Table 4.2 Donors and donations demand for the population of Algarve in 2060 in four different 
projection scenarios 
 
Projection 
scenarios 
Population of 
Algarve (No) 
Population of 
Algarve 15-64 (No) 
Donors demand 
(average) 
Donations 
demand (average) 
A
lg
a
rv
e 
2
0
6
0
 
Low 319 930,00 162 837,00 1 954,84 8 171,29 
Central 454 489,00 252 910,00 3 036,15 12 691,23 
High 486 967,00 261 876,00 3 143,79 13 141,15 
without 
migration 
345 651,00 181 930,00 2 184,05 9 129,39 
Mean 401 759 214 888 2 580 10 783 
Source: INE (2014); author´s calculation 
 
 It was calculated the projection of the average number of donors, the average 
demand of RCC and the number of donations for 2060 and results were compared with 
the results in 2013 (Table 4.3). The numerical values of the population of Algarve in 2060 
resulted from the average of the four scenarios provided by the INE (INE, 2014b).  
 
Table 4.3 Comparison of 2013 and 2060: Population of Algarve, number of donors, donations and RCC 
transfusion (average) in CHA 
 Sources: ASIS (2015) and INE (2015); author´s calculation 
 
 According to the results, we will witness in 2060 a decrease of 9.2% of the whole 
population of Algarve, leading to a decrease of 24.5% of the blood donors and donations. 
On the other hand, RCC demand will increase 34.8%. 
 We calculated the number that would correspond to an increase of 24.5% of RCC 
(average), given that it was the percentage of the decrease of both donor and donation 
numbers: 
 Population of Algarve (No) Donors No (average) Donations No RCC No (average) 
2013 442 358 3 416 14 279 115 
2060 401 759 2 580 10 783 155 
Diference ↓ 40 599 = 9.18% ↓ 836 = 24.47% ↓ 3 496 = 24.48% ↑ 41 = 34.78% 
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𝒙 =
155 ∗ 124,5%
134,8%
= 𝟏𝟒𝟑, 𝟏𝟖  
 
 Then the achieved number was used to calculate the year in which that would 
happen. Therefore we have an increase of 24.5% that corresponds to a demand of an 
average of 143.2 RCC. After the application of the forecasting expression, we came to 
the following results (Table 4.4 and Figure 4.1): 
Table 4.4 Year forecast for the RCC (average): 143 
Year RCC No 
(average) 
2013 115 
2060 155 
2046 143 
     Source: Excel (2015); author´s calculation 
 
               Figure 4.1 Forecast expression and results presentation for 2013, 2046 and 2060 
 
Source: Excel (2015); author´s calculation 
 
 From the available information and with the presented scenarios, we can observe 
that the number of donors/donations will equal the number of transfused RCC (average) 
in the year 2046. 
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Chapter 5. CONCLUSIONS 
In summary, it was demonstrated by linear regression and statistical tools that the 
blood supply versus demand may turn into an issue in a medium-long term future. The 
encouragement of self-committed young aged donors is a priority. However, research and 
development by introducing red blood cell substitutes can make a twist in the mentioned 
scenarios. 
As Lownik et al. (2012) concluded, I believe it is important to have a good 
understanding of the knowledge, attitude, practices and behaviours of the potential 
donors, in order to stimulate their first donations and at the same time capture them for a 
long stand commitment. Donor mobilization programmes should include educational 
elements to enhance their awareness of the importance of serving others in a local and 
wider community for humanitarian and healthcare related causes.   
Altruism is the most motivating factor for blood donation (Evans and Ferguson, 
2014; Lownik et al., 2012). Increasing the correspondence between advocated and 
primary motives of the target audience is important for the effectiveness of recruitment 
campaigns (Evans and Ferguson, 2014). 
Captivation of young people to perform donation is imperative. The sooner a 
donor starts donating, the more donations are to be expected during his shelf-life as a 
blood donor. Raising awareness campaigns regarding donations starting at the age of 18, 
as well doing it regularly, should be strongly encouraged, as some values, such as 
citizenship, healthy life, sense of belonging, kindness, helping others, should be more 
rooted along education. Although considered a non-remunerated and altruistic gesture, 
some existing incentives in Portugal should remain in place, such as moderating fees 
exemption for donors when donating twice a year. 
On the other hand, Good Transfusion Practices are extremely important. The 
clinical transfusion process comprehends the transfusion of the right blood unit to the 
right patient in the right time under right conditions and appropriate guidelines. It is an 
integrated network of events beginning with the decision to transfuse and ending with the 
assessment of its efficacy and safety. The objective is to optimize the blood utilization 
(Optimal Blood Use, 2010).  
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Patient Blood Management (PBM) is an evidence-based multidisciplinary 
approach to optimize the care of patients who might need transfusion. It includes all 
aspects of patient evaluation and clinical management surrounding the transfusion 
decision-making process, including the application of appropriate indications, the 
avoidance of  transfusion of blood if not needed, minimization of blood loss and 
optimization of patient red cell mass (AABB, 2015). Transfusion Committees have 
played an important role in its implementation. Although CHA is a hospital from group 
II that does not have the valences and complexity of pathologies that might be problematic 
in terms of transfusion, PBM is a broad scope discipline and can be regarded as an 
opportunity for continuous improvement.  
Donor management, Good Transfusion Practices and PBM remain a challenge for 
Blood Transfusion Services. A multidisciplinary and multi-skill approach is essential to 
maintain the necessary response to the hospital and the Algarve population needs in terms 
of transfusion.  
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Appendix 1 
Outliers 2011 
Percentiles 
 
Percentiles 
5 10 25 50 75 90 95 
Weighted Average(Definition 1) RCC No 1.00 3.00 30.00 99.00 207.00 368.00 418.00 
Tukey's Hinges RCC No   30.00 99.00 202.50   
 
 
Extreme Values 
 Case Number Value 
RCC No Highest 1 99.00 518.00 
2 98.00 470.00 
3 97.00 445.00 
4 96.00 423.00 
5 95.00 418.00 
Lowest 1 4.00 0.00 
2 3.00 0.00 
3 2.00 0.00 
4 1.00 0.00 
5 6.00 1.00a 
a. Only a partial list of cases with the value 1 are shown in the 
table of lower extremes. 
 
Outliers 2012 
 
Percentiles 
 
Percentiles 
5 10 25 50 75 90 95 
Weighted Average(Definition 1) RCC 1.00 4.00 31.00 79.00 210.00 376.00 423.00 
Tukey's Hinges RCC   31.50 79.00 210.00   
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Extreme Values 
 Case Number Value 
RCC Highest 1 99.00 625.00 
2 98.00 438.00 
3 97.00 424.00 
4 95.00 423.00 
5 96.00 423.00 
Lowest 1 4.00 0.00 
2 3.00 0.00 
3 2.00 0.00 
4 1.00 0.00 
5 7.00 1.00a 
a. Only a partial list of cases with the value 1 are shown in 
the table of lower extremes. 
 
Outliers 2013 
Percentiles 
 
Percentiles 
5 10 25 50 75 90 95 
Weighted Average(Definition 1) RCC 2.00 4.00 18.00 77.00 221.00 351.00 390.00 
Tukey's Hinges RCC   18.50 77.00 204.50   
 
Extreme Values 
 Case Number Value 
RCC Highest 1 99.00 534.00 
2 98.00 523.00 
3 97.00 429.00 
4 96.00 392.00 
5 95.00 390.00 
Lowest 1 2.00 0.00 
2 1.00 0.00 
3 3.00 1.00 
4 7.00 2.00 
5 6.00 2.00a 
a. Only a partial list of cases with the value 2 are shown in 
the table of lower extremes. 
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Outliers 2014 
 
Percentiles 
 
Percentiles 
5 10 25 50 75 90 95 
Weighted Average(Definition 1) RCC 2.00 8.00 30.00 86.00 240.00 333.00 403.00 
Tukey's Hinges RCC   31.00 86.00 237.00   
 
 
Extreme Values 
 Case Number Value 
RCC Highest 1 86.00 455.00 
2 83.00 432.00 
3 80.00 415.00 
4 81.00 409.00 
5 79.00 403.00 
Lowest 1 16.00 1.00 
2 11.00 1.00 
3 3.00 1.00 
4 13.00 2.00 
5 10.00 2.00a 
a. Only a partial list of cases with the value 2 are shown in 
the table of lower extremes. 
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Attachment A 
Resident population by age groups (No.), Portugal and NUTS II , 2008-2013 
         
  Portugal North Centre Lisbon Alentejo Algarve 
R. A. 
Azores 
R. A. 
Madeira 
Population aged 0 to 14 years old (No.) 
2008 1 630 985  586 299  336 159  440 612  104 894  69 322  46 658  47 041 
2009 1 617 993  575 081  332 147  443 605  104 525  70 460  45 866  46 309 
2010 1 595 173  561 737  324 531  443 945  103 676  70 919  44 874  45 491 
2011 1 572 900  549 344  316 891  446 810  102 447  69 440  44 237  43 731 
2012 1 550 201  535 720  310 487  448 181  101 049  68 943  43 386  42 435 
2013 1 521 854  520 775  303 099  447 308  99 171  68 069  42 479  40 953 
Population aged 15 to 64 years old (No.) 
2008 7 033 726 2 538 611 1 513 215 1 862 338  480 916  288 336  168 910  181 400 
2009 7 025 090 2 531 922 1 509 237 1 861 162  478 468  291 413  169 588  183 300 
2010 7 001 126 2 516 869 1 501 939 1 857 562  475 482  294 397  170 067  184 810 
2011 6 961 852 2 510 813 1 489 936 1 845 263  472 700  289 708  170 990  182 442 
2012 6 904 482 2 493 688 1 477 585 1 823 009  468 668  287 313  171 998  182 221 
2013 6 835 604 2 471 127 1 461 752 1 799 138  464 895  284 551  172 692  181 449 
Population of 65 and more years old (No.) 
2008 1 898 303  587 644  492 433  489 155  178 842  82 430  31 102  36 697 
2009 1 930 396  598 977  496 403  503 438  179 075  83 951  31 446  37 106 
2010 1 976 422  614 979  505 172  521 254  179 549  85 988  31 816  37 664 
2011 2 007 646  627 067  509 342  534 977  179 238  86 992  31 967  38 063 
2012 2 032 606  636 826  510 866  547 198  178 982  88 134  32 165  38 435 
2013 2 069 843  652 293  516 313  561 079  179 240  89 738  32 269  38 911 
                  
 
 
 
 
 
 
 
 
 
 
 
